BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+9.42%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.21B
AUM Growth
+$243M
(+6.1%)
Cap. Flow
+$15M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108
Top Buys
| 1 |
Netflix
NFLX
|
+$23.5M |
| 2 |
IBM
IBM
|
+$20.5M |
| 3 |
AbbVie
ABBV
|
+$20.4M |
| 4 |
Advanced Micro Devices
AMD
|
+$20.4M |
| 5 |
Palantir
PLTR
|
+$20.3M |
Top Sells
| 1 |
TTM Technologies
TTMI
|
+$19.8M |
| 2 |
Pfizer
PFE
|
+$19.1M |
| 3 |
Qualcomm
QCOM
|
+$19.1M |
| 4 |
Comcast
CMCSA
|
+$19.1M |
| 5 |
Intel
INTC
|
+$19.1M |
Sector Composition
| 1 | Financials | 28.39% |
| 2 | Consumer Discretionary | 12.55% |
| 3 | Technology | 11.6% |
| 4 | Industrials | 11.34% |
| 5 | Energy | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Karyopharm Therapeutics
KPTI
$53.8M
| $163K | ﹤0.01% |
+37,836
| New | +$163K |
|
1002
Harte-Hanks
HHS
$27.4M
| $163K | ﹤0.01% |
40,846
| – | – |
|
1003
KORU Medical Systems
KRMD
$187M
| $162K | ﹤0.01% |
45,305
| – | – |
|
1004
MacroGenics
MGNX
$109M
| $162K | ﹤0.01% |
133,700
+18,500
| +16% | +$22.4K |
|
1005
Alector
ALEC
$287M
| $161K | ﹤0.01% |
+115,000
| New | +$161K |
|
1006
Lyell Immunopharma
LYEL
$251M
| $159K | ﹤0.01% |
+18,000
| New | +$159K |
|
1007
Myomo
MYO
$33M
| $159K | ﹤0.01% |
73,600
| – | – |
|
1008
PMV Pharmaceuticals
PMVP
$67.3M
| $158K | ﹤0.01% |
148,800
| – | – |
|
1009
Network-1 Technologies
NTIP
$36.5M
| $157K | ﹤0.01% |
128,701
-1,694
| -1% | -$2.07K |
|
1010
Pyxis Oncology
PYXS
$116M
| $157K | ﹤0.01% |
142,295
+61,500
| +76% | +$67.7K |
|
1011
Pathfinder Bancorp
PBHC
$92.8M
| $156K | ﹤0.01% |
10,200
| – | – |
|
1012
Usio Inc
USIO
$38.7M
| $155K | ﹤0.01% |
101,000
| – | – |
|
|
AFCG
1013
AFC Gamma
AFCG
$102M
| $153K | ﹤0.01% |
34,096
| – | – |
|
1014
GoHealth
GOCO
$75.9M
| $150K | ﹤0.01% |
27,066
+2,058
| +8% | +$11.4K |
|
1015
C4 Therapeutics
CCCC
$188M
| $150K | ﹤0.01% |
104,900
-25,000
| -19% | -$35.8K |
|
1016
Bridger Aerospace
BAER
$106M
| $148K | ﹤0.01% |
76,700
+65,000
| +556% | +$125K |
|
1017
Metagenomi
MGX
$69.1M
| $146K | ﹤0.01% |
98,700
| – | – |
|
1018
Nkarta
NKTX
$143M
| $146K | ﹤0.01% |
87,800
| – | – |
|
1019
Sypris Solutions
SYPR
$44.9M
| $144K | ﹤0.01% |
65,204
| – | – |
|
1020
Assertio
ASRT
$77.5M
| $143K | ﹤0.01% |
223,401
-40,000
| -15% | -$25.6K |
|
1021
OptimumBank Holdings
OPHC
$50.5M
| $141K | ﹤0.01% |
31,600
| – | – |
|
|
ALTS
1022
ALT5 Sigma Corporation Common Stock
ALTS
$490M
| $140K | ﹤0.01% |
19,339
+1,661
| +9% | +$12K |
|
1023
Seres Therapeutics
MCRB
$154M
| $139K | ﹤0.01% |
12,500
| – | – |
|
1024
PEDEVCO
PED
$55.1M
| $139K | ﹤0.01% |
212,191
| – | – |
|
1025
Apyx Medical
APYX
$74.5M
| $139K | ﹤0.01% |
61,601
-30,000
| -33% | -$67.5K |
|